The Chiefs continue their losing preseason ways and the Eagles try to snap a losing skid vs the Steelers in Week 3 NFL preseason betting this week.
The Pittsburgh Steelers are 5-2 SU and 6-1 ATS in their last seven preseason games against the Philadelphia Eagles.
The Eagles will try to break an 0-4 ATS streak against the Steelers with a win on Thursday night as a 3.5-point favorite as NFL preseason betting kicks off Week 3.
Pittsburgh was 1-5 SU and 0-6 ATS in its last six preseason games heading into last week, finally breaking the slump with a 19-16 win over Buffalo as a 1-point favorite at home, according to one book.
The Steelers are 0-3 SU and ATS in their last three preseason road games and have lost outright in each of their last two preseason trips to Philadelphia.
On Friday, the Carolina Panthers are a 5.5-point road underdog visiting the New England Patriots. New England has dominated this preseason series in recent years with a 4-1 SU and 4-0-1 ATS record against the Panthers over the last five preseason meetings between these two teams. The Patriots are also 3-0 SU and ATS over their last three preseason home games.
Fading the Oakland Raiders on the road has been a very strong preseason play over the last eight seasons. The Raiders are 2-14 SU and 5-11 ATS over their last 16 preseason road games including a current stretch of failing to beat the NFL odds at 0-7 SU and 1-6 ATS.
They'll try to snap out of their road futility as a 7-point underdog against Green Bay on Friday.
Dallas is just 4-11 SU and ATS in its last 15 preseason road games. The Cowboys are 0-4 SU and ATS in their last four preseason games played on the road, averaging only 12.75 points per game over that stretch. Miami is a 3.5-point favorite at home.
Minnesota is an ugly 1-6 SU and ATS over its last seven preseason road games. Kansas City is a 3.5-point favorite and will be looking for a rare cover on Saturday. The Chiefs, after an ATS loss and a push so far, are now a bankroll-depleting 7-31-2 ATS over their last 40 preseason games overall.